カテゴリ： QYResearch, 世界, 医療/バイオ

ウェアラブルインジェクターシステムの世界市場2023年：オンボディ、オフボディ

■ 英語タイトル：Global Wearable Injector System Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8512）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8512
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：101
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ウェアラブルインジェクターシステムの世界市場2023年：オンボディ、オフボディ]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はウェアラブルインジェクターシステムのグローバル市場について調査・分析し、世界のウェアラブルインジェクターシステム市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（オンボディ、オフボディ）、用途別セグメント分析（病院、クリニック、在宅医療）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、BD、Sonceboz、Ypsomed、Elcam Medical、Enable Injections、Johnson & Johnson、United Therapeutics、West Pharmaceutical、CeQur Simplicity、Neuma、CCBio、Nemera、Amgen、Eitan Medical、Debiotech、MET、Weibel CDS、Repathaなどが含まれています。ウェアラブルインジェクターシステムのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ウェアラブルインジェクターシステム市場規模を算出する際に考慮しました。

・ウェアラブルインジェクターシステム市場の概要
- 製品の定義
- ウェアラブルインジェクターシステムの種類別セグメント
- 世界のウェアラブルインジェクターシステム市場規模：タイプ別分析（オンボディ、オフボディ）
- ウェアラブルインジェクターシステムの用途別セグメント
- 世界のウェアラブルインジェクターシステム市場規模：用途別分析（病院、クリニック、在宅医療）
- 世界のウェアラブルインジェクターシステム市場規模予測（2018年-2029年）
- ウェアラブルインジェクターシステムの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ウェアラブルインジェクターシステム市場の競争状況およびトレンド

・ウェアラブルインジェクターシステムの地域別市場規模
- 北米のウェアラブルインジェクターシステム市場規模（2018年-2029年）
- 米国のウェアラブルインジェクターシステム市場規模（2018年-2029年）
- ヨーロッパのウェアラブルインジェクターシステム市場規模（2018年-2029年）
- アジア太平洋のウェアラブルインジェクターシステム市場規模（2018年-2029年）
- 中国のウェアラブルインジェクターシステム市場規模（2018年-2029年）
- 日本のウェアラブルインジェクターシステム市場規模（2018年-2029年）
- 韓国のウェアラブルインジェクターシステム市場規模（2018年-2029年）
- インドのウェアラブルインジェクターシステム市場規模（2018年-2029年）
- オーストラリアのウェアラブルインジェクターシステム市場規模（2018年-2029年）
- 中南米のウェアラブルインジェクターシステム市場規模（2018年-2029年）
- 中東・アフリカのウェアラブルインジェクターシステム市場規模（2018年-2029年）

・種類別セグメント：オンボディ、オフボディ
- 世界のウェアラブルインジェクターシステムのタイプ別販売量（2018年-2023年）
- 世界のウェアラブルインジェクターシステムのタイプ別売上（2018年-2023年）
- 世界のウェアラブルインジェクターシステムのタイプ別価格

・用途別セグメント：病院、クリニック、在宅医療
- 世界のウェアラブルインジェクターシステムの用途別販売量（2018年-2023年）
- 世界のウェアラブルインジェクターシステムの用途別売上（2018年-2023年）
- 世界のウェアラブルインジェクターシステムの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
BD、Sonceboz、Ypsomed、Elcam Medical、Enable Injections、Johnson & Johnson、United Therapeutics、West Pharmaceutical、CeQur Simplicity、Neuma、CCBio、Nemera、Amgen、Eitan Medical、Debiotech、MET、Weibel CDS、Repatha

・産業チェーンと販売チャネルの分析
- ウェアラブルインジェクターシステム産業チェーン分析
- ウェアラブルインジェクターシステムの主要原材料
- ウェアラブルインジェクターシステムの販売チャネル
- ウェアラブルインジェクターシステムのディストリビューター
- ウェアラブルインジェクターシステムの主要顧客

・ウェアラブルインジェクターシステム市場ダイナミクス
- ウェアラブルインジェクターシステムの業界動向
- ウェアラブルインジェクターシステム市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Wearable Injector System market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Wearable Injector System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Wearable Injector System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Wearable Injector System include BD, Sonceboz, Ypsomed, Elcam Medical, Enable Injections, Johnson & Johnson, United Therapeutics, West Pharmaceutical and CeQur Simplicity, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Wearable Injector System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Injector System.
The Wearable Injector System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Wearable Injector System market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wearable Injector System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
BD
Sonceboz
Ypsomed
Elcam Medical
Enable Injections
Johnson & Johnson
United Therapeutics
West Pharmaceutical
CeQur Simplicity
Neuma
CCBio
Nemera
Amgen
Eitan Medical
Debiotech
MET
Weibel CDS
Repatha
Segment by Type
On-body
Off-body
Segment by Application
Hospitals
Clinics
Home Care
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wearable Injector System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wearable Injector System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Wearable Injector System Market Overview
1.1 Product Overview and Scope of Wearable Injector System
1.2 Wearable Injector System Segment by Type
1.2.1 Global Wearable Injector System Market Value Comparison by Type (2023-2029)
1.2.2 On-body
1.2.3 Off-body
1.3 Wearable Injector System Segment by Application
1.3.1 Global Wearable Injector System Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Wearable Injector System Market Size Estimates and Forecasts
1.4.1 Global Wearable Injector System Revenue 2018-2029
1.4.2 Global Wearable Injector System Sales 2018-2029
1.4.3 Global Wearable Injector System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Wearable Injector System Market Competition by Manufacturers
2.1 Global Wearable Injector System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Wearable Injector System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Wearable Injector System Average Price by Manufacturers (2018-2023)
2.4 Global Wearable Injector System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Wearable Injector System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Wearable Injector System, Product Type & Application
2.7 Wearable Injector System Market Competitive Situation and Trends
2.7.1 Wearable Injector System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Wearable Injector System Players Market Share by Revenue
2.7.3 Global Wearable Injector System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Wearable Injector System Retrospective Market Scenario by Region
3.1 Global Wearable Injector System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Wearable Injector System Global Wearable Injector System Sales by Region: 2018-2029
3.2.1 Global Wearable Injector System Sales by Region: 2018-2023
3.2.2 Global Wearable Injector System Sales by Region: 2024-2029
3.3 Global Wearable Injector System Global Wearable Injector System Revenue by Region: 2018-2029
3.3.1 Global Wearable Injector System Revenue by Region: 2018-2023
3.3.2 Global Wearable Injector System Revenue by Region: 2024-2029
3.4 North America Wearable Injector System Market Facts & Figures by Country
3.4.1 North America Wearable Injector System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Wearable Injector System Sales by Country (2018-2029)
3.4.3 North America Wearable Injector System Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Wearable Injector System Market Facts & Figures by Country
3.5.1 Europe Wearable Injector System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Wearable Injector System Sales by Country (2018-2029)
3.5.3 Europe Wearable Injector System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Wearable Injector System Market Facts & Figures by Country
3.6.1 Asia Pacific Wearable Injector System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Wearable Injector System Sales by Country (2018-2029)
3.6.3 Asia Pacific Wearable Injector System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Wearable Injector System Market Facts & Figures by Country
3.7.1 Latin America Wearable Injector System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Wearable Injector System Sales by Country (2018-2029)
3.7.3 Latin America Wearable Injector System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Wearable Injector System Market Facts & Figures by Country
3.8.1 Middle East and Africa Wearable Injector System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Wearable Injector System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Wearable Injector System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Wearable Injector System Sales by Type (2018-2029)
4.1.1 Global Wearable Injector System Sales by Type (2018-2023)
4.1.2 Global Wearable Injector System Sales by Type (2024-2029)
4.1.3 Global Wearable Injector System Sales Market Share by Type (2018-2029)
4.2 Global Wearable Injector System Revenue by Type (2018-2029)
4.2.1 Global Wearable Injector System Revenue by Type (2018-2023)
4.2.2 Global Wearable Injector System Revenue by Type (2024-2029)
4.2.3 Global Wearable Injector System Revenue Market Share by Type (2018-2029)
4.3 Global Wearable Injector System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Wearable Injector System Sales by Application (2018-2029)
5.1.1 Global Wearable Injector System Sales by Application (2018-2023)
5.1.2 Global Wearable Injector System Sales by Application (2024-2029)
5.1.3 Global Wearable Injector System Sales Market Share by Application (2018-2029)
5.2 Global Wearable Injector System Revenue by Application (2018-2029)
5.2.1 Global Wearable Injector System Revenue by Application (2018-2023)
5.2.2 Global Wearable Injector System Revenue by Application (2024-2029)
5.2.3 Global Wearable Injector System Revenue Market Share by Application (2018-2029)
5.3 Global Wearable Injector System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Corporation Information
6.1.2 BD Description and Business Overview
6.1.3 BD Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BD Wearable Injector System Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Sonceboz
6.2.1 Sonceboz Corporation Information
6.2.2 Sonceboz Description and Business Overview
6.2.3 Sonceboz Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sonceboz Wearable Injector System Product Portfolio
6.2.5 Sonceboz Recent Developments/Updates
6.3 Ypsomed
6.3.1 Ypsomed Corporation Information
6.3.2 Ypsomed Description and Business Overview
6.3.3 Ypsomed Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ypsomed Wearable Injector System Product Portfolio
6.3.5 Ypsomed Recent Developments/Updates
6.4 Elcam Medical
6.4.1 Elcam Medical Corporation Information
6.4.2 Elcam Medical Description and Business Overview
6.4.3 Elcam Medical Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Elcam Medical Wearable Injector System Product Portfolio
6.4.5 Elcam Medical Recent Developments/Updates
6.5 Enable Injections
6.5.1 Enable Injections Corporation Information
6.5.2 Enable Injections Description and Business Overview
6.5.3 Enable Injections Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Enable Injections Wearable Injector System Product Portfolio
6.5.5 Enable Injections Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Johnson & Johnson Wearable Injector System Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 United Therapeutics
6.6.1 United Therapeutics Corporation Information
6.6.2 United Therapeutics Description and Business Overview
6.6.3 United Therapeutics Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 United Therapeutics Wearable Injector System Product Portfolio
6.7.5 United Therapeutics Recent Developments/Updates
6.8 West Pharmaceutical
6.8.1 West Pharmaceutical Corporation Information
6.8.2 West Pharmaceutical Description and Business Overview
6.8.3 West Pharmaceutical Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 West Pharmaceutical Wearable Injector System Product Portfolio
6.8.5 West Pharmaceutical Recent Developments/Updates
6.9 CeQur Simplicity
6.9.1 CeQur Simplicity Corporation Information
6.9.2 CeQur Simplicity Description and Business Overview
6.9.3 CeQur Simplicity Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 CeQur Simplicity Wearable Injector System Product Portfolio
6.9.5 CeQur Simplicity Recent Developments/Updates
6.10 Neuma
6.10.1 Neuma Corporation Information
6.10.2 Neuma Description and Business Overview
6.10.3 Neuma Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Neuma Wearable Injector System Product Portfolio
6.10.5 Neuma Recent Developments/Updates
6.11 CCBio
6.11.1 CCBio Corporation Information
6.11.2 CCBio Wearable Injector System Description and Business Overview
6.11.3 CCBio Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.11.4 CCBio Wearable Injector System Product Portfolio
6.11.5 CCBio Recent Developments/Updates
6.12 Nemera
6.12.1 Nemera Corporation Information
6.12.2 Nemera Wearable Injector System Description and Business Overview
6.12.3 Nemera Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Nemera Wearable Injector System Product Portfolio
6.12.5 Nemera Recent Developments/Updates
6.13 Amgen
6.13.1 Amgen Corporation Information
6.13.2 Amgen Wearable Injector System Description and Business Overview
6.13.3 Amgen Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Amgen Wearable Injector System Product Portfolio
6.13.5 Amgen Recent Developments/Updates
6.14 Eitan Medical
6.14.1 Eitan Medical Corporation Information
6.14.2 Eitan Medical Wearable Injector System Description and Business Overview
6.14.3 Eitan Medical Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Eitan Medical Wearable Injector System Product Portfolio
6.14.5 Eitan Medical Recent Developments/Updates
6.15 Debiotech
6.15.1 Debiotech Corporation Information
6.15.2 Debiotech Wearable Injector System Description and Business Overview
6.15.3 Debiotech Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Debiotech Wearable Injector System Product Portfolio
6.15.5 Debiotech Recent Developments/Updates
6.16 MET
6.16.1 MET Corporation Information
6.16.2 MET Wearable Injector System Description and Business Overview
6.16.3 MET Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.16.4 MET Wearable Injector System Product Portfolio
6.16.5 MET Recent Developments/Updates
6.17 Weibel CDS
6.17.1 Weibel CDS Corporation Information
6.17.2 Weibel CDS Wearable Injector System Description and Business Overview
6.17.3 Weibel CDS Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Weibel CDS Wearable Injector System Product Portfolio
6.17.5 Weibel CDS Recent Developments/Updates
6.18 Repatha
6.18.1 Repatha Corporation Information
6.18.2 Repatha Wearable Injector System Description and Business Overview
6.18.3 Repatha Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Repatha Wearable Injector System Product Portfolio
6.18.5 Repatha Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Wearable Injector System Industry Chain Analysis
7.2 Wearable Injector System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Wearable Injector System Production Mode & Process
7.4 Wearable Injector System Sales and Marketing
7.4.1 Wearable Injector System Sales Channels
7.4.2 Wearable Injector System Distributors
7.5 Wearable Injector System Customers
8 Wearable Injector System Market Dynamics
8.1 Wearable Injector System Industry Trends
8.2 Wearable Injector System Market Drivers
8.3 Wearable Injector System Market Challenges
8.4 Wearable Injector System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Wearable Injector System Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Wearable Injector System Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Wearable Injector System Market Competitive Situation by Manufacturers in 2022
Table 4. Global Wearable Injector System Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Wearable Injector System Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Wearable Injector System Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Wearable Injector System Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Wearable Injector System Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Wearable Injector System, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Wearable Injector System, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Wearable Injector System, Product Type & Application
Table 12. Global Key Manufacturers of Wearable Injector System, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Wearable Injector System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wearable Injector System as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Wearable Injector System Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Wearable Injector System Sales by Region (2018-2023) & (K Units)
Table 18. Global Wearable Injector System Sales Market Share by Region (2018-2023)
Table 19. Global Wearable Injector System Sales by Region (2024-2029) & (K Units)
Table 20. Global Wearable Injector System Sales Market Share by Region (2024-2029)
Table 21. Global Wearable Injector System Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Wearable Injector System Revenue Market Share by Region (2018-2023)
Table 23. Global Wearable Injector System Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Wearable Injector System Revenue Market Share by Region (2024-2029)
Table 25. North America Wearable Injector System Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Wearable Injector System Sales by Country (2018-2023) & (K Units)
Table 27. North America Wearable Injector System Sales by Country (2024-2029) & (K Units)
Table 28. North America Wearable Injector System Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Wearable Injector System Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Wearable Injector System Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Wearable Injector System Sales by Country (2018-2023) & (K Units)
Table 32. Europe Wearable Injector System Sales by Country (2024-2029) & (K Units)
Table 33. Europe Wearable Injector System Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Wearable Injector System Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Wearable Injector System Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Wearable Injector System Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Wearable Injector System Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Wearable Injector System Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Wearable Injector System Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Wearable Injector System Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Wearable Injector System Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Wearable Injector System Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Wearable Injector System Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Wearable Injector System Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Wearable Injector System Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Wearable Injector System Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Wearable Injector System Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Wearable Injector System Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Wearable Injector System Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Wearable Injector System Sales (K Units) by Type (2018-2023)
Table 51. Global Wearable Injector System Sales (K Units) by Type (2024-2029)
Table 52. Global Wearable Injector System Sales Market Share by Type (2018-2023)
Table 53. Global Wearable Injector System Sales Market Share by Type (2024-2029)
Table 54. Global Wearable Injector System Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Wearable Injector System Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Wearable Injector System Revenue Market Share by Type (2018-2023)
Table 57. Global Wearable Injector System Revenue Market Share by Type (2024-2029)
Table 58. Global Wearable Injector System Price (US$/Unit) by Type (2018-2023)
Table 59. Global Wearable Injector System Price (US$/Unit) by Type (2024-2029)
Table 60. Global Wearable Injector System Sales (K Units) by Application (2018-2023)
Table 61. Global Wearable Injector System Sales (K Units) by Application (2024-2029)
Table 62. Global Wearable Injector System Sales Market Share by Application (2018-2023)
Table 63. Global Wearable Injector System Sales Market Share by Application (2024-2029)
Table 64. Global Wearable Injector System Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Wearable Injector System Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Wearable Injector System Revenue Market Share by Application (2018-2023)
Table 67. Global Wearable Injector System Revenue Market Share by Application (2024-2029)
Table 68. Global Wearable Injector System Price (US$/Unit) by Application (2018-2023)
Table 69. Global Wearable Injector System Price (US$/Unit) by Application (2024-2029)
Table 70. BD Corporation Information
Table 71. BD Description and Business Overview
Table 72. BD Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. BD Wearable Injector System Product
Table 74. BD Recent Developments/Updates
Table 75. Sonceboz Corporation Information
Table 76. Sonceboz Description and Business Overview
Table 77. Sonceboz Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Sonceboz Wearable Injector System Product
Table 79. Sonceboz Recent Developments/Updates
Table 80. Ypsomed Corporation Information
Table 81. Ypsomed Description and Business Overview
Table 82. Ypsomed Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Ypsomed Wearable Injector System Product
Table 84. Ypsomed Recent Developments/Updates
Table 85. Elcam Medical Corporation Information
Table 86. Elcam Medical Description and Business Overview
Table 87. Elcam Medical Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Elcam Medical Wearable Injector System Product
Table 89. Elcam Medical Recent Developments/Updates
Table 90. Enable Injections Corporation Information
Table 91. Enable Injections Description and Business Overview
Table 92. Enable Injections Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Enable Injections Wearable Injector System Product
Table 94. Enable Injections Recent Developments/Updates
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Johnson & Johnson Wearable Injector System Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. United Therapeutics Corporation Information
Table 101. United Therapeutics Description and Business Overview
Table 102. United Therapeutics Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. United Therapeutics Wearable Injector System Product
Table 104. United Therapeutics Recent Developments/Updates
Table 105. West Pharmaceutical Corporation Information
Table 106. West Pharmaceutical Description and Business Overview
Table 107. West Pharmaceutical Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. West Pharmaceutical Wearable Injector System Product
Table 109. West Pharmaceutical Recent Developments/Updates
Table 110. CeQur Simplicity Corporation Information
Table 111. CeQur Simplicity Description and Business Overview
Table 112. CeQur Simplicity Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. CeQur Simplicity Wearable Injector System Product
Table 114. CeQur Simplicity Recent Developments/Updates
Table 115. Neuma Corporation Information
Table 116. Neuma Description and Business Overview
Table 117. Neuma Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Neuma Wearable Injector System Product
Table 119. Neuma Recent Developments/Updates
Table 120. CCBio Corporation Information
Table 121. CCBio Description and Business Overview
Table 122. CCBio Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. CCBio Wearable Injector System Product
Table 124. CCBio Recent Developments/Updates
Table 125. Nemera Corporation Information
Table 126. Nemera Description and Business Overview
Table 127. Nemera Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Nemera Wearable Injector System Product
Table 129. Nemera Recent Developments/Updates
Table 130. Amgen Corporation Information
Table 131. Amgen Description and Business Overview
Table 132. Amgen Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Amgen Wearable Injector System Product
Table 134. Amgen Recent Developments/Updates
Table 135. Eitan Medical Corporation Information
Table 136. Eitan Medical Description and Business Overview
Table 137. Eitan Medical Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Eitan Medical Wearable Injector System Product
Table 139. Eitan Medical Recent Developments/Updates
Table 140. Debiotech Corporation Information
Table 141. Debiotech Description and Business Overview
Table 142. Debiotech Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Debiotech Wearable Injector System Product
Table 144. Debiotech Recent Developments/Updates
Table 145. MET Corporation Information
Table 146. MET Description and Business Overview
Table 147. MET Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. MET Wearable Injector System Product
Table 149. MET Recent Developments/Updates
Table 150. Weibel CDS Corporation Information
Table 151. Weibel CDS Description and Business Overview
Table 152. Weibel CDS Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Weibel CDS Wearable Injector System Product
Table 154. Weibel CDS Recent Developments/Updates
Table 155. Repatha Corporation Information
Table 156. Repatha Description and Business Overview
Table 157. Repatha Wearable Injector System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Repatha Wearable Injector System Product
Table 159. Repatha Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Wearable Injector System Distributors List
Table 163. Wearable Injector System Customers List
Table 164. Wearable Injector System Market Trends
Table 165. Wearable Injector System Market Drivers
Table 166. Wearable Injector System Market Challenges
Table 167. Wearable Injector System Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Wearable Injector System
Figure 2. Global Wearable Injector System Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Wearable Injector System Market Share by Type in 2022 & 2029
Figure 4. On-body Product Picture
Figure 5. Off-body Product Picture
Figure 6. Global Wearable Injector System Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Wearable Injector System Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Home Care
Figure 11. Global Wearable Injector System Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Wearable Injector System Market Size (2018-2029) & (US$ Million)
Figure 13. Global Wearable Injector System Sales (2018-2029) & (K Units)
Figure 14. Global Wearable Injector System Average Price (US$/Unit) & (2018-2029)
Figure 15. Wearable Injector System Report Years Considered
Figure 16. Wearable Injector System Sales Share by Manufacturers in 2022
Figure 17. Global Wearable Injector System Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Wearable Injector System Players: Market Share by Revenue in 2022
Figure 19. Wearable Injector System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Wearable Injector System Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Wearable Injector System Sales Market Share by Country (2018-2029)
Figure 22. North America Wearable Injector System Revenue Market Share by Country (2018-2029)
Figure 23. United States Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Wearable Injector System Sales Market Share by Country (2018-2029)
Figure 26. Europe Wearable Injector System Revenue Market Share by Country (2018-2029)
Figure 27. Germany Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Wearable Injector System Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Wearable Injector System Revenue Market Share by Region (2018-2029)
Figure 34. China Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Wearable Injector System Sales Market Share by Country (2018-2029)
Figure 44. Latin America Wearable Injector System Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Wearable Injector System Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Wearable Injector System Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Wearable Injector System Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Wearable Injector System by Type (2018-2029)
Figure 54. Global Revenue Market Share of Wearable Injector System by Type (2018-2029)
Figure 55. Global Wearable Injector System Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Wearable Injector System by Application (2018-2029)
Figure 57. Global Revenue Market Share of Wearable Injector System by Application (2018-2029)
Figure 58. Global Wearable Injector System Price (US$/Unit) by Application (2018-2029)
Figure 59. Wearable Injector System Value Chain
Figure 60. Wearable Injector System Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ウェアラブルインジェクターのグローバル市場2024-2030：オンボディ、オフボディ
  • ウェアラブル注射器のグローバル市場：オンボディ、オフボディ
  • ウェアラブル患者モニタリングデバイスの世界市場2023年：スマートウォッチ、ウェアラブル診断機器、ウェアラブル治療機器
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8512 )"ウェアラブルインジェクターシステムの世界市場2023年：オンボディ、オフボディ" (英文：Global Wearable Injector System Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。